On the final day of the 2019 election campaign, the outcome is uncertain; pollsters cannot predict with any confidence which party will be in a position to govern after the ballots have been counted later today. The Liberals and Conservatives find themselves neck and neck in this race, with neither seemingly able to garner enough…
Read More
Dr. Ryan Wiley President, Shift Health Policy Advisor, Research Canada In just a few days, Canadians will be choosing among platforms and positions to elect their next government. And while healthcare remains a perennial concern, health research and science are almost undetectable in public discourse: our politicians aren’t talking about science, and the public doesn’t…
Read MoreAs Canada’s leading mental health research facility, The Centre for Addiction and Mental Health (CAMH) aims to inspire hope through discovery. We are revolutionizing our understanding of the brain and the causes, biomarkers and treatments for mental illness. We are transforming the way we do research so that all CAMH patients and staff have a…
Read MoreSeveral media commentators have noted that the 2019 federal election campaign is lacking in big, bold ideas, and the quality of political debate has accordingly suffered. I suspect most Canadians feel the same. While the media is drawn to stories of controversy and scandal, during an election campaign most Canadians want to hear about the…
Read MoreIncredible scientific and technological advances in recent years have improved our collective understanding of many rare diseases. This is a very exciting time for the rare disease community. These diseases are often severe conditions that affect a very small population – fewer than one in 2,000 Canadians. However, too many Canadians cannot benefit from these…
Read More
Canadians are well-served by the Federal Government’s goal to position Canada as a world leader in the development and manufacturing of innovative products and services. Bausch Health shares this focus in our development, distribution, and manufacturing of pharmaceutical products and technologies for Canadians. Our suite of products and technologies spans several therapeutic areas including dermatology, cardiovascular and mental health, to name a…
Read More
As a critical step towards bringing new medicines and vaccines safely to market, clinical trials provide Canadians with access to new, potentially life-saving medications and therapies. These trials have been proven to increase the speed at which Canadian healthcare professionals and hospitals adopt healthcare innovations. The pharmaceutical industry’s investments in clinical trials not only help…
Read MoreWith the Green Party poised to gain a record number of seats in the 2019 election, its most important contribution to the next Parliament may be its strong support for the science and research sector. While we are still waiting to see the Conservative Platform, it seems safe to say that the Green Party platform…
Read MoreToday more than ever, health care research requires a truly interdisciplinary approach. This means bringing researchers out of their silos and facilitating their working together to solve the complex health care problems we are facing. At Concordia University, we are uniquely positioned to conduct innovative health care research that moves past traditional disciplines. Over the…
Read More
With an ambition to push the boundaries of science and advance understanding of the underlying biology of disease, AstraZeneca has built one of the strongest small molecule and biologics pipelines in the biopharmaceutical industry. At the heart of our work is a deep commitment to addressing unmet medical need and delivering life-changing medicines to patients.…
Read More